  **Abbreviations, acronyms & symbols**   
  --------------------------------------- ---------------------------------
  CABG                                    Coronary artery bypass
  CAD                                     Coronary artery disease
  CRP                                     Cardiac rehabilitation program
  GCR                                     Group of cardiac rehabilitation
  IMT                                     Inspiratory muscle training
  Peak VO~2~                              Peak oxygen consumption
  PEmax                                   Maximal expiratory pressure
  PImax                                   Maximal inspiratory pressure
  RMS                                     Respiratory muscle strength

INTRODUCTION
============

Cardiovascular diseases are the leading cause of death and disability in Brazil and worldwide. According to the World Health Organization, 7.3 million deaths worldwide were due to coronary artery disease (CAD) in 2008^\[[@r01]\]^. According to Datasus, in Brazil in 2009 there were 209,029 hospital admissions due to CAD, totaling 12,619 deaths with a mortality rate of 6.04%^\[[@r02]\]^.

Despite advances in clinical therapy and percutaneous interventions, coronary artery bypass grafting (CABG) is still widely used in the treatment of patients with CAD because it can control persistent ischemia and its progression to acute myocardial infarction, as well as provide symptomatic relief and prevent ischemic complications^\[[@r03]\]^. However, cardiac surgery is a complex procedure that triggers major organ repercussions, which changes the physiology of patients in many ways^\[[@r04]\]^.

In this sense, it has been suggested that respiratory muscle dysfunctions associated with decreased functional capacity contribute to the prolonged period of lung function recovery and the occurrence of physical deconditioning, which can last several weeks in patients submitted to CABG^\[[@r05],[@r06]\]^.

Several studies have demonstrated the effectiveness of inspiratory muscle training (IMT) in restoration of ventilatory function, decrease in the length of hospital stay, and improvement of functional capacity and quality of life (QoL) of patients who underwent CABG and are in phase I cardiac rehabilitation program (CRP)^\[[@r07]-[@r10]\]^. Onishi et al.^\[[@r11]\]^ found that the inclusion of resistance training combined with aerobic training for six months during phase II CRP was beneficial to patients with metabolic syndrome submitted to CABG. However, the short-term effects of IMT in patients in phase II CRP after CABG and its association with aerobic and resistance training have been largely unexplored in the literature and require further elucidation. Therefore, the aim of this study was to investigate the efficiency of short-term IMT associated with combined aerobic and resistance training on respiratory muscle strength (RMS), functional capacity, and QoL in patients who underwent CABG and are in phase II CRP.

METHODS
=======

Study design
------------

A prospective quasi-experimental study was conducted among patients who underwent CABG and were recruited from the waiting list for a phase II CRP at the Outpatient Cardiology Clinic of Hospital Universitário de Santa Maria (HUSM), Santa Maria, RS, Brazil. The eligibility criteria included patients undergoing CABG up to three weeks before the initiation of the study at HUSM, a clinical course without complications during hospitalization, the absence of smoking (previous or current), and agreement to participate. Patients with chronic obstructive pulmonary disease, unstable angina, acute decompensated heart failure, acute pericarditis or myocarditis, complex arrhythmias, uncontrolled hypertension, severe orthopedic or neurological disorders, uncontrolled diabetes, and labyrinthitis were excluded.

The study was approved by the Research Ethics Committee of Universidade Federal de Santa Maria (UFSM) under protocol no. 16149813.3.0000.5346 and was conducted in accordance with the Guidelines and Norms Regulating Research Involving Humans established by Resolution no. 466/2012 of the National Health Council.

Patients and Intervention
-------------------------

Patients eligible for the study were initially assessed via anamnesis, physical examination, and evaluation of inspiratory muscle strength. Subsequently, these patients were randomly allocated to phase II of the CRP into two groups: a group subjected to CRP+IMT (GCR+IMT) followed the IMT protocol in addition to the combined training (aerobic and resistance training) and a group subjected to CRP (GCR) followed the combined training protocol and performed breathing exercises for 12 weeks. An RMS test was conducted before and after the intervention, and the functional capacity and QoL were evaluated. All evaluations were conducted by investigators blinded to the allocation of patients into the intervention groups.

Cardiac Rehabilitation Program
------------------------------

All patients participated in the CRP for a period of 12 weeks, with two sessions per week (24 sessions). Each session lasted 60 minutes, and all sessions were under the direct supervision of a physical therapist. The training program consisted of a combination of aerobic and resistance exercises, 30 minutes of aerobic exercise on a treadmill and exercise bike, 20 minutes of resistance exercises for the arms (latissimus dorsal m.,biceps brachii m., triceps brachii m., deltoid m., trapezius m., pectoralis major m., pectoralis major m., and rhomboid m) and legs (femoral quadriceps m., hip adductors m. and hip abductors m.) with dumbbells, ankle weights, or elastic bands (3 sets of exercises for each muscle group performed with 10 repetitions with the intensity adjusted to 50% of the load of one maximum repetition - 1MR), and 10 minutes of stretching and relaxation. Heart rate, blood pressure, and peripheral oxygen saturation were measured at the beginning, during, immediately after, and five minutes after each session.

The exercise intensity was based on the percentage of heart rate reserve, calculated as the difference between the maximum heart rate obtained in the exercise stress test and the resting heart rate, with the establishment of an intensity of 55%-65%^\[[@r12]\]^ and a score of 4-6 on the modified Borg scale (ranging between 0 and 10).

In addition to the CRP, the participants performed diaphragmatic stimulation and fractionated breathing patterns (short inspirations during three intervals with a mild inspiratory pause) to achieve a diaphragmatic breathing pattern similar to that performed by the GCR+IMT.

Inspiratory Muscle Training
---------------------------

The participants assigned to the GCR+IMT group were subjected to IMT, using the IMT Threshold^®^ equipment (Threshold Inspiratory Muscle Trainer, Health Scan Products Inc., Cedar Grove, NJ, USA) in 3 sets of 10 repetitions with an inspiratory load of 30% of the maximal inspiratory pressure (PImax)^\[[@r13]\]^. During training, the participants remained seated with the nose occluded by a nose clip and were advised to maintain a diaphragmatic breathing pattern and a respiratory rate between 15 and 20 cycles per minute. Each week, the training load was adjusted to maintain 30% of the PImax.

Assessment of Respiratory Muscle Strength
-----------------------------------------

PImax and maximal expiratory pressure (PEmax) were measured using a digital manometer (MVD-300, Globalmed, Porto Alegre, RS, Brazil)^\[[@r14]\]^. A 2-mm orifice in the system kept the glottis open and prevented any interference from pressure produced by facial muscles. First, the subjects were instructed to remain in a seated position. A demonstration of how the maneuvers should be carried out was given and then performed by the subject after the placement of a nose clip. The subjects were instructed to keep their lips sealed tightly around the mouthpiece so no air could escape. PImax values were obtained by inspiration from residual volume^\[[@r14]\]^, which was repeated at least three times with a one-minute interval between repetitions. PEmax was obtained by expiration from total lung capacity, using the same methodology applied in inspiration. During the PImax maneuver, the subject kept the mouthpiece in the oral cavity only during the inspiration, and in the PEmax maneuver, only during expiration.

The maneuvers were sustained at maximal force for approximately one second and the highest value was computed from a minimum of three repetitions for each maneuver, with a maximum difference of 10% between values and they were then compared to the predicted values according to the equations proposed by Neder et al.^\[[@r15]\]^.

Assessment of Functional Capacity
---------------------------------

Functional capacity was evaluated by exercise testing (ET) using a standard Bruce protocol and assessed with peak oxygen consumption (peak VO~2~). The values of peak VO~2~ were obtained by use of a treadmill stress test (Imbramed^®^ KT 10200, Sao Paulo, Brazil), and the analysis of peak VO~2~ was carried out using the Ergo PC version 2.2 (Micromed^TM^, Brazil) software. The ET was performed according to the guidelines of the Brazilian Society of Cardiology/Department of Exercise, Ergometry, and Cardiovascular Rehabilitation^\[[@r16]\]^.

Evaluation of Quality of Life
-----------------------------

QoL was assessed with the Portuguese version of the Minnesota Living with Heart Failure Questionnaire (MLwHFQ)^\[[@r17]\]^.

Sample size calculation
-----------------------

To estimate the sample size, a pilot study was conducted using a protocol identical to that described above in a group of five patients. A sampling error of 2%, a two-sided alpha of 5%, a statistical power of 80%, and a difference of 20.6±9.6 cmH~2~O in variation of PImax between the groups were considered as well as a 10% loss to follow-up, thus resulting in the inclusion of at least nine patients per group.

Statistical Analysis
--------------------

Data were analyzed using the statistical software SPSS version 20.0. The normality of the variables was assessed with the Shapiro-Wilk test. Categorical data are presented as absolute frequencies and percentages. Continuous data with normal distribution are expressed as means and standard deviations. Student\'s t-test for paired samples was used to compare the data before and after the intervention. The baseline data and the variation between pre- and post-CRP values between groups were compared using the independent Student\'s t-test, except for the categorical variables, which were compared by the Chi-square test. A value of *P*\<0.05 was considered statistically significant.

RESULTS
=======

Of the 28 eligible patients, four were excluded for not meeting the inclusion criteria. Therefore, 24 patients were included in the study. Of these, 12 patients were allocated to the GCR and 12 were allocated to the GCR+IMT. No adverse events were observed during the CRP and adherence to the program was considered excellent.

The demographic, anthropometric, and clinical characteristics of both groups are shown in [Table 1](#t02){ref-type="table"}. No significant differences were observed between the two groups.

###### 

Demographic and clinical characteristics of patients participating in the study.

  Baseline characteristics                           GCR (*n*=12)   GCR+IMT (*n*=12)   *P*
  -------------------------------------------------- -------------- ------------------ -------
  Age (years)                                        59.5±8.7       55.2±7.9           0.313
  Male gender, n (%)                                 10 (83.3)      7 (58.3)           0.178
  BMI (Kg/m^2^)                                      28.4±3.8       30.7±4.4           0.274
  Diabetes, n (%)                                    4 (33.33)      3 (25.0)           0.500
  Hypertension, n (%)                                4 (33.33)      5 (41.6)           0.312
  Ejection fraction (%)                              65.2±9.9       63.5±3.6           0.640
  NYHA                                                                                  
      I, n (%)                                       2 (16.7)       3 (25.0)           0.849
      II, n (%)                                      8 (66.7)       6 (50.0)           0.408
      III, n (%)                                     2 (16.7)       3 (25.0)           0.849
  Extent of disease (%)                                                                 
  2-vessel                                           54.3           50.5               0.285
  3-vessel                                           45.7           49.5                
  Extracorporeal circulation, n (%)                  12 (100)       12 (100)           \-
  Duration of hospitalization after surgery (days)   6.7±1.7        7.1±1.5            0.657
  Peak VO~2~ (mL.Kg^1^.min^-1^)                      26.0±5.6       25.5±3.7           0.802
  Peak VO~2~^2^ (% predicted)                        88.1±23.0      86.4±16.0          0.836
  PImax (c^2^mH~2~O)                                 72.0±8.1       67.8±9.0           0.782
  PImax (% predicted)                                71.4±13.8      70.4±11.1          0.856
  PEmax (cmH~2~O)                                    87.3±11.0      86.6±25.9          0.936
  PEmax (% predicted)                                80.2±13.9      86.1±27.7          0.518
  MLwHFQ (score)                                     39.9±12.6      41.0±19.0          0.871
  Medication, n (%)                                                                     
      Acetylsalicylic acid                           8 (66.6)       6 (50.0)           0.408
      Clopidogrel or triclopidine                    2 (16.7)       1 (8.3)            0.500
      Statin                                         6 (50.0)       6 (50.0)           1.000
      Diuretics                                      4 (33.3)       3 (25.0)           0.500
      Warfarin                                       1 (8.3)        2 (16.7)           0.500
      ACEI or ARB                                    4 (33.3)       5 (41.6)           0.500
      Beta-blockers                                  8 (66.6)       9 (75.0)           1.000

Data are expressed as mean ± standard deviation or absolute values and percentages.

ACEI=angiotensin-converting enzyme inhibitor; ARB=angiotensin II receptor blocker; BMI=body mass index; GCR=cardiac rehabilitation group; GCR+IMT=cardiac rehabilitation group + inspiratory muscle training program; MLwHFQ=Minnesota living with heart failure questionnaire; NYHA=New York Heart Association; Peak VO2=peak oxygen consumption; PEmax=maximal expiratory pressure; PImax=maximal inspiratory pressure

A significant increase in PImax and PEmax was observed after CRP in both groups. However, the variation between pre- and post-CRP values was significantly higher in the GCR+IMT ([Table 2](#t03){ref-type="table"}).

###### 

Comparison of respiratory muscle strength between groups.

  Variables             GCR (n=12)   GCR+IMT (n=12)                                                                        
  --------------------- ------------ ---------------- --------- --------- ----------- ------------- ---------- ----------- ---------
  PEmax (cmH~2~O)       87.3±11.0    89.8±10.5        2.3±0.8   0.004     86.6±25.9   108.1 ±17.1   21.5±8.5   \<0.001     \<0.001
  PEmax (% predicted)   80.2±13.9    82.2±15.6        2.5±0.8   0.038     86.1±27.7   108.1±21.1    22.0±7.7   \<0.001     \<0.001
  PImax (cmH~2~O)       72.0±8.3     77.0±5.8         4.9±0.2   \<0.001   67.8±9.0    96.7±21.3     28.9±7.9   \<0.00      \<0.001
  PImax (% predicted)   71.4±13.8    76.4±12.8        4.7±0.9   \<0.001   70.4±11.1   99.6±16.7     29.1±5.6   1 \<0.001   \<0.001

Data are expressed as mean ± standard deviation.

GCR=cardiac rehabilitation group; GCR+IMT=cardiac rehabilitation group + inspiratory muscle training program; PEmax=maximal expiratory pressure; Pimax=maximal inspiratory pressure

P-value derived using paired Student's t-test, after checking for normal distributions.

P-value derived using independent Student's t-test for comparison of variation between the groups.

Regarding functional capacity, it was observed that in the pre-CRP phase, the GCR group achieved approximately 88% of predicted peak VO~2~ whereas patients in the GCR+IMT achieved approximately 86% ([Table 1](#t02){ref-type="table"}). After intervention, patients in the GCR + IMT improved significantly their peak VO~2~. Additionally, the variation of peak VO~2~ was significantly higher in the GCR+TMI compared to the GCR, and a similar result was demonstrated for the percent-predicted peak VO~2~ (% predicted peak VO~2~) ([Figures 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}).

![Comparison of peak oxygen consumption (peak VO~2~) between groups.](rbccv-30-04-0474-g01){#f01}

![Comparison of peak oxygen consumption (% predicted) between groups.](rbccv-30-04-0474-g02){#f02}

The total MLwHFQ scores decreased significantly in both groups, indicating improvement in QoL, however, the variation in MLwHFQ scores was significantly higher in the GCR + IMT ([Figure 3](#f03){ref-type="fig"}).

![Comparison of change in QoL score, assessed with Minnesota Living with Heart Failure questionnaire (MLwHFQ), between groups.](rbccv-30-04-0474-g03){#f03}

DISCUSSION
==========

The present study found that a short-term IMT program associated with combined aerobic and resistance training had a more pronounced effect on respiratory muscle strength, functional capacity and QoL than combined aerobic and resistance training alone in patients who underwent CABG surgery and are in phase II CRP. To the best of our knowledge, this is the first study to address the additional short-term effects of IMT associated with combined training in this patient population.

Despite the current lack of evidence demonstrating the benefits of IMT in patients who underwent CABG surgery and are in phase II CRP, it is important to mention the pioneering study of Winkelmann et al.^\[[@r18]\]^, which also investigated the potential additional benefits of IMT combined with aerobic training for 12 weeks, although in a different population (patients with chronic heart failure - CHF). Their study demonstrated that the addition of IMT to aerobic exercise resulted in additional improvement in PImax compared to aerobic exercise alone, and these results were similar to those reported in this study. Recently, Laoutaris et al.^\[[@r19]\]^, using a protocol similar to ours, showed that IMT associated with combined aerobic and resistance training in 27 patients with CHF, without inspiratory muscle weakness, is safe, and resulted in incremental benefits in PImax compared with the effects of aerobic training alone.

Studies have been conducted to evaluated the effects of combined aerobic and resistance training on functional capacity of patients undergoing CABG. Onishi et al.^\[[@r11]\]^ and Sumide et al.^\[[@r20]\]^ showed that combined training induced significant improvement in peak VO~2~ in this patient population. In contrast, Arthur et al.^\[[@r21]\]^, in a randomized controlled trial to compare the effect of 6 months of combined aerobic and resistance training vs aerobic training alone in women undergoing CABG, reported that after the exercise training program both groups showed statistically significant improvements in peak VO~2~.

In the present study, even over a relatively short-term period, it was observed that IMT associated with combined aerobic and resistance training provides a significant improvement in functional capacity when compared to combined training. These results indicate that the addition of IMT may have complementary effects to those obtained with combined training on functional capacity of patients who underwent CABG and are in phase II CRP. One potential explanation of this finding is that the IMT program, even over a short-term period, improves systemic vasodilation and perfusion of peripheral muscles^\[[@r22]\]^, promoting a more pronounced effect on functional capacity in these patients. Laoutaris et al.^\[[@r23]\]^ showed that addition of IMT program to aerobic training in patients with ventricular assist device resulted in an additional improvement in peak VO~2~, compared with the effects of aerobic training alone.

Regarding QoL, the values of MLwHFQ scores improved significantly in both groups. However, the IMT group showed a higher variation in MLwFQ scores. These changes may explain the additional improvement in QoL with IMT associated with combined training. Few studies have evaluated the impact of IMT associated with aerobic and resistance training on QoL specifically in patients who underwent CABG and are in phase II CRP. The addition of IMT to training programs is becoming more widespread as a potential non-pharmacological therapeutic intervention to improve QoL of patients with CHF^\[[@r18],[@r19]\]^. Recently, Adamopoulos et al.^\[[@r24]\]^, in a 12-week prospective randomized multicenter study, have reported that IMT associated with aerobic training improves QoL in patients with CHF.

We consider that our results are relevant because even a short-term IMT program performed just twice a week with a lower inspiratory resistive loading intensity improved the variables analyzed, although it was carried out in patients without respiratory muscle weakness. Furthermore, these findings are consistent with results of previous studies conducted with patients with CHF subjected to the IMT program, though performed at higher weekly frequency and with a higher inspiratory loading intensity training protocol.

Some study limitations should be considered. First, our sample included only 24 patients submitted to CABG. However, it is of note that the number of patients who participate in phase II CRP in Brazil is extremely low. Second, an inspiratory muscle endurance testing was not performed. The third limitation is related to learning the technique of assessment of respiratory muscle strength. This test depends on the understanding and cooperation of participating individuals. Therefore, the technique can have a determinative positive effect on the outcome. This aspect can be considered as qualitatively influencing the results of the present study.

CONCLUSION
==========

This study demonstrates that a short-term IMT program associated with aerobic and resistance training in patients undergoing phase II of a CRP after CABG resulted in significantly large increments in respiratory muscle strength, functional capacity, and QoL. Our single-center findings also indicate that the addition of IMT, even when applied for a short period, can complement and enhance the effects of combined aerobic and resistance training and could become a simple and inexpensive adjuvant treatment, improving the efficiency of phase II cardiac rehabilitation programs within the public health system. Future large multicenter studies are needed to provide definitive proof of these benefits.
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